237 related articles for article (PubMed ID: 35165456)
1. Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics.
Tsai K; Stojković V; Lee DJ; Young ID; Szal T; Klepacki D; Vázquez-Laslop N; Mankin AS; Fraser JS; Fujimori DG
Nat Struct Mol Biol; 2022 Feb; 29(2):162-171. PubMed ID: 35165456
[TBL] [Abstract][Full Text] [Related]
2. The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning.
Wilson DN; Schluenzen F; Harms JM; Starosta AL; Connell SR; Fucini P
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13339-44. PubMed ID: 18757750
[TBL] [Abstract][Full Text] [Related]
3. Context-specific inhibition of translation by ribosomal antibiotics targeting the peptidyl transferase center.
Marks J; Kannan K; Roncase EJ; Klepacki D; Kefi A; Orelle C; Vázquez-Laslop N; Mankin AS
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12150-12155. PubMed ID: 27791002
[TBL] [Abstract][Full Text] [Related]
4. R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.
Skripkin E; McConnell TS; DeVito J; Lawrence L; Ippolito JA; Duffy EM; Sutcliffe J; Franceschi F
Antimicrob Agents Chemother; 2008 Oct; 52(10):3550-7. PubMed ID: 18663023
[TBL] [Abstract][Full Text] [Related]
5. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action.
Xiong L; Kloss P; Douthwaite S; Andersen NM; Swaney S; Shinabarger DL; Mankin AS
J Bacteriol; 2000 Oct; 182(19):5325-31. PubMed ID: 10986233
[TBL] [Abstract][Full Text] [Related]
6. A noncanonical binding site of linezolid revealed via molecular dynamics simulations.
Makarov GI; Makarova TM
J Comput Aided Mol Des; 2020 Mar; 34(3):281-291. PubMed ID: 31832846
[TBL] [Abstract][Full Text] [Related]
7. Putting the antibiotics chloramphenicol and linezolid into context.
Crowe-McAuliffe C; Wilson DN
Nat Struct Mol Biol; 2022 Feb; 29(2):79-81. PubMed ID: 35165457
[No Abstract] [Full Text] [Related]
8. Resistance to linezolid caused by modifications at its binding site on the ribosome.
Long KS; Vester B
Antimicrob Agents Chemother; 2012 Feb; 56(2):603-12. PubMed ID: 22143525
[TBL] [Abstract][Full Text] [Related]
9. The chemistry of peptidyltransferase center-targeted antibiotics: enzymatic resistance and approaches to countering resistance.
McCusker KP; Fujimori DG
ACS Chem Biol; 2012 Jan; 7(1):64-72. PubMed ID: 22208312
[TBL] [Abstract][Full Text] [Related]
10. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.
Leach KL; Swaney SM; Colca JR; McDonald WG; Blinn JR; Thomasco LM; Gadwood RC; Shinabarger D; Xiong L; Mankin AS
Mol Cell; 2007 May; 26(3):393-402. PubMed ID: 17499045
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for PoxtA-mediated resistance to phenicol and oxazolidinone antibiotics.
Crowe-McAuliffe C; Murina V; Turnbull KJ; Huch S; Kasari M; Takada H; Nersisyan L; Sundsfjord A; Hegstad K; Atkinson GC; Pelechano V; Wilson DN; Hauryliuk V
Nat Commun; 2022 Apr; 13(1):1860. PubMed ID: 35387982
[TBL] [Abstract][Full Text] [Related]
12. Madumycin II inhibits peptide bond formation by forcing the peptidyl transferase center into an inactive state.
Osterman IA; Khabibullina NF; Komarova ES; Kasatsky P; Kartsev VG; Bogdanov AA; Dontsova OA; Konevega AL; Sergiev PV; Polikanov YS
Nucleic Acids Res; 2017 Jul; 45(12):7507-7514. PubMed ID: 28505372
[TBL] [Abstract][Full Text] [Related]
13. Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes.
Aoki H; Ke L; Poppe SM; Poel TJ; Weaver EA; Gadwood RC; Thomas RC; Shinabarger DL; Ganoza MC
Antimicrob Agents Chemother; 2002 Apr; 46(4):1080-5. PubMed ID: 11897593
[TBL] [Abstract][Full Text] [Related]
14. Structural Basis for Linezolid Binding Site Rearrangement in the
Belousoff MJ; Eyal Z; Radjainia M; Ahmed T; Bamert RS; Matzov D; Bashan A; Zimmerman E; Mishra S; Cameron D; Elmlund H; Peleg AY; Bhushan S; Lithgow T; Yonath A
mBio; 2017 May; 8(3):. PubMed ID: 28487427
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibiotic.
Scaiola A; Leibundgut M; Boehringer D; Caspers P; Bur D; Locher HH; Rueedi G; Ritz D
Sci Rep; 2019 Apr; 9(1):5634. PubMed ID: 30948752
[TBL] [Abstract][Full Text] [Related]
16. Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center.
Kloss P; Xiong L; Shinabarger DL; Mankin AS
J Mol Biol; 1999 Nov; 294(1):93-101. PubMed ID: 10556031
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol.
Syroegin EA; Flemmich L; Klepacki D; Vazquez-Laslop N; Micura R; Polikanov YS
Nat Struct Mol Biol; 2022 Feb; 29(2):152-161. PubMed ID: 35165455
[TBL] [Abstract][Full Text] [Related]
18. The oxazolidinone class of drugs find their orientation on the ribosome.
Wilson DN; Nierhaus KH
Mol Cell; 2007 May; 26(4):460-2. PubMed ID: 17531804
[No Abstract] [Full Text] [Related]
19. On the structural basis of peptide-bond formation and antibiotic resistance from atomic structures of the large ribosomal subunit.
Steitz TA
FEBS Lett; 2005 Feb; 579(4):955-8. PubMed ID: 15680981
[TBL] [Abstract][Full Text] [Related]
20. An Update on the Structure of Oxazolidinone Analogs and a Comparison with Linezolid in Terms of In Vitro and Intracellular Efficacy against Clinically Relevant Bacterial Species.
Tang Q; Zhao Y; Xu B; Gong P; Wang D
Jpn J Infect Dis; 2017 Nov; 70(6):678-681. PubMed ID: 28890512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
